B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NR1D2

MOLECULAR TARGET

nuclear receptor subfamily 1 group D member 2

UniProt: NP_001138897NCBI Gene: 99751 compounds

NR1D2 (nuclear receptor subfamily 1 group D member 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NR1D2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Heme1.393

About NR1D2 as a Drug Target

NR1D2 (nuclear receptor subfamily 1 group D member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented NR1D2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NR1D2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.